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Departments of Vascular and Endovascular Surgery, St James's University Hospital, Beckett Street, 
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Objectives: To determine if ceil-salvaged autologous blood can serve as an alternative to homologous blood, and to 
examine the incidence of infected complications and length of postoperative stay. 
Design: A prospective randomised study comprising autologous and homologous blood transfusions in patients undergoing 
elective infrarenal abdominal aortic surgery. 
Methods: Fifty patients undergoing AAA surgery were prospectively randomised to homologous blood (n=27), or 
autologous blood transfusion (n=23), using a cell salvage autotransfusion device. 
Results: The haemoglobin at the time of hospital discharge was similar for both groups (11.0 vs. lO.8 g/dl) with no 
difference in perioperative mortality. The length of stay was reduced in those patients who received autologous blood (9 
days vs. 12 days, p<O.05 Mann-Whitney U test). There were four infected cases in the autologous group and 12 in the 
homologous group (p=n.s., Fisher's exact probability test). However, patients who received 3-4 units of homologous 
blood had an increased risk of infection compared to those who received a similar amount of autologous blood (50% vs. 
0%). 
Conclusions: Cell salvage autologous blood can safely replace, or at least decrease, exposure to homologous blood 
transfusion, with a reduction in the mean hospital stay. 
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Introduction 
Blood transfusion has assumed a major role in the 
development of modern medical and surgical practice. 
However, it involves side effects and risks that have 
been well documented over the years. These risks 
have been dramatically reduced by accurate donor 
screening, safer blood processing and more reliable 
pretransfusion testing. Nevertheless, today i in 5 trans- 
fused units of blood still cause some adverse effect 
that can be serious enough to compromise the outcome 
of highly complex surgical procedures. 1'2
It has been proposed that patients receiving ho- 
mologous blood transfusions have an increased risk of 
postoperative bacterial infections. 3-s Increasing num- 
bers of homologous transfusions are also a major in- 
dependent predictor of septic complications after 
trauma. 6 Other proposed consequences of homologous 
transfusions include improved success rates for renal 
allografts, 7 increased rates of solid tumour recur- 
rence, s-ll and a decreased rate of recurrence of Crohn's 
disease. 12The proposed mechanism for such effects 
centre on impaired immunological function in the trans- 
fused patient. Despite many studies on these clinically 
important questions, the answers remain unclear. Most 
studies in human beings have been retrospective or
hampered by the lack of adequate controls, and the 
results have been even more confusing. 13-15 
Intraoperative autotransfusion (IAT) has been 
shown to be a safe and effective method of salvaging 
autologous blood lost during operation, and there is 
no indication that autologous blood transfusion leads 
to any significant immunosuppression. 16 19 We there- 
fore used IAT as a control for the hypothetical effect 
of homologous blood. The aims of our study were to 
perform apilot study to determine if it was possible to 
perform elective infrarenal abdominal ortic aneurysm 
repair using IAT alone, and to determine the incidence 
of postoperative infection and hospital stay in a single 
University teaching hospital, in patients receiving ho- 
mologous blood (HBT) or IAT. 
Patients 
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Table 1. Characteristics of study patients. 
Autologous blood Homologous blood 
(n =23) (n =27) 
M/F 19/4 20/7 
Age (Median & IQRs) 71 (54-78) 68 (54-82) 
Smoking 17 23 
Diabetes 5 4 
Ischaemic heart disease 14 17 
Haemoglobin (g/dl) 
(median &IQRs) 
Admission 13.5 (12.7-14.5) 12.8 (10.5-15.2) 
Discharge 11.0 (10.3-12.0) 10.8 (10.0-12.9) 
Aortic cross clamp time 
(mins) (median &IQRs) 40 (35-60) 43 (27-55) 
Anaesthetic me (mins) 
(median &IQRs) 150 (120-240) 144 (135-225) 
Blood loss (ml) 
(median &IQRs) 1800 (500-2800) 1500 (500-3045) 
50 patients, 39 men and 11 women with a median age 
of 70 (range 54-82), who underwent elective infrarenal 
abdominal aortic aneurysm repair (Table 1). 
The patients were prospectively randomised using 
sealed envelopes to receive either homologous blood 
(n=27) or autologous blood (n=23) via IAT. They 
were transfused with homologous blood if the haem- 
atocrit fell below 25%, as surgical patients tolerate 
limited dilutional anaemia providing the blood volume 
is maintained and adequate arterial oxygen saturation 
is provided, a°
Methods 
The COBE Baylor apid autologous transfusion system 
(COBE laboratories Inc. Lakewood, Colorado, U.S.A.) 
was employed in all cases as the intraoperative c ll- 
saver. The cell-saver apparatus was monitored and 
operated by a trained operating department assistant. 
In brief, blood is retrieved from the operative site 
by suctioning into a double lumen catheter at a vacuum 
pressure <150mmHg, to minimise haemolysis. The 
blood is anticoagulated immediately with heparin 
(30000U heparin/1000ml of 0.9% saline). The 
salvaged blood is then collected in a reservoir where 
a macrofilter of 150 microns removes larger particles 
of debris. When 500 ml of blood has been collected, it
is pumped to a spinning centrifuge bowl. The red cells 
are packed against he outer wall of the centrifuge 
bowl, washed with 0.9% saline, and concentrated to a 
haematocrit above 50%. The effluent containing 
plasma fractions, platelets, leukocytes, free haemo- 
globin, anticoagulant and saline is discarded. The 
washed red cells, suspended in saline, are pumped 
from the centrifuge to a reinfusion bag and can be 
returned to the patient hrough a microfilter of either 
20 or 40 microns. Anticoagulation is monitored uring 
the operation by measurement of he activated clotting 
time, since heparin is removed in the washing process. 
Data collection 
The following parameters were collected on all 
patients; preoperative haemoglobin, estimated blood 
lost (suction and swab weight), intraoperative and 
postoperative homologous blood transfused, amount 
of autologous blood given, and postoperative haemo- 
globin values on postoperative day 1 and day of 
discharge. The development of sepsis, and systemic 
inflammatory esponse syndrome (SIRS), as proposed 
by the American College of Chest Physicians-Society 
of Critical Care Medicine (ACCP/SCCM) (Table 1). 21 
In addition, the length of postoperative stay was also 
noted. 
Statistical analysis 
The results are expressed as medians and interquartile 
ranges, and the Mann-Whitney U test was used as 
the test of significance. The groups were compared by 
Chi-squared tests with Yate's correction or Fisher's 
exact test when appropriate. Patients were analysed 
on an intention-to-treat b sis. 
Results 
There were no deaths in this study. 
Pre- and postoperative haemoglobin values 
There was no significant difference between the me- 
dian admission haemoglobin concentration (auto- 
logous group Hb 13.5g/dl [range 12.7-14.5] vs. 
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Table 2. ACCP/SCCM definition of SIRS and sepsis. 
SIRS 
Sepsis 
Signs of a systemic response (two of the following): 
Fever or hypothermia (core or rectal temperature 
>38.4 °C or <35.6 °C). 
Tachycardia (Heart rate >90 beats/rain). 
Tachypnoea (respiration >20 breaths/rain [ifpatient 
is mechanically ventilated, >10 I/min]) or 
White blood cell count >12 x 109/1 or <4 x 109/1 or 
the presence of more than 0.1% immature 
neutrophils. 
The presence of SIRS associated with a confirmed 
infectious process. 
homologous group Hb 12.8g/dl  [10.5-15.2]). In- 
terestingly, there was no difference between the me- 
dian haemoglobin concentration atthe time of hospital 
discharge (autologous group Hb 11.0 g /d l  [10.3-12.0] 
vs homologous group Hb 10.8 g /d l  [10.0-112.9]) (Table 
2). 
Blood loss 
There was no significant difference in blood loss be- 
tween the HBT group, median 1500 ml vs. 1800 ml for 
the IAT group. 
Blood transfusion requirements 
In this study 96% of patients in the HBT group and 
100% of the IAT group required a blood transfusion 
in the perioperative period. In the IAT group three 
(13%) patients received homologous blood during their 
AAA repair: two because of an error in the autologous 
blood collection during the early part of the study, 
and one returned to theatre because of a proximal 
anastomotic leak. The proportions who required 2 
units or more of blood did not differ significantly 
between the groups (Table 3). The median blood re- 
quirements for the HBT group was 2.96 units per case, 
and 3.29 units per case for the IAT group. 
Postoperative infections 
The study groups were similar in terms of distribution 
of risk factors for infectious complications. 
Systemic inflammatory esponse syndrome 
Three patients in the IAT group and nine patients in 
the HBT group developed a systemic inflammatory 
response (p = 0.088, Table 4). 
Sepsis 
There were no cases of sepsis in the IAT group and 
three cases in the HBT group, all due to pneumonia. 
Although the analysis of infectious complications 
showed a tendency to more events in the HBT group 
(4/23 [17.3%] vs. 12/27 [44%]), the difference was not 
statistically significant (p = 0.07, Fisher's exact test). 
Multiple blood transfusions 
The infection rate increased with the number of trans- 
fused blood units (Table 5) and was higher in the HBT 
group than the IAT group for all categories, except 
patients who received >4 units of blood. The severity 
of infection in those patients requiring more than 4 
units of blood was less in the tAT group compared to 
the HBT group (Table 4). Of the four patients in the 
HBT group who received >4 units of blood, three 
developed sepsis and one developed signs of SIRS, 
while the patients in the IAT group showed signs 
of SIRS only. Twelve patients received 3-4 units of 
homologous blood, with six developing SIRS com- 
pared to none of the 13 patients who received auto- 
logous blood (p = 0.025, Fisher's exact probability test). 
Table 3. Details of transfusion requirements. 
Autologous blood Homologous blood 
n=23 n=27 
Total number of units transferred 75 80 
No. (%) patients receiving: 0 (0) 1 (4%) 
No units 
1-2 units 7 (30%) 10 (37%) 
>2 units 16 (70%) 16 (59%) 
Homologous units transfused 11 68 
No. (%) patients transfused with 3 (13%) 26 (96%) 
homologous blood 
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Table 4. Incidence of postoperative infections. 
Autologous blood Homologous blood p 
(n =23) (n =27) 
No. of cases of SIRS 3 9 n.s. 
No. of cases of sepsis 0 3 n.s. 
Days of antibiotics 4 (1%) 7 (1-14) <0.01 
Days of fever 2 (1-5) 3 (1-7) n.s. 
Length of postoperative stay 9 (7-13) 12 (7-19) <0.05 
Results are expressed asmedians and interquartile ranges and analysed with a Mann- 
Whitney U test. 
Table 5. Increase in infection rate with number of blood transfusions. 
Unit of blood transfused Autologous blood Homologous blood p 
n No. with infection n No. with infection 
0 0 0 1 0 n.s. 
1-2 7 0 10 2 n.s. 
34 13 0 12 6 0.025 
>4 3 3 4 4 n.s. 
Length of stay 
The duration of hospital stay was significantly reduced 
in those receiving autologous blood, with a median 
stay of 9 days (range 7-13) vs. a median stay of 12 
days (range 7-19) in the homologous blood group 
(p<0.05, Mann-Whitney U test). 
Discussion 
The hazards of homologous transfusion have been 
reduced, but not eliminated, by modern blood banking 
methods. The small risk associated with a single trans- 
fusion is compounded for the patient who requires 
multiple units of blood. Vascular surgeons now see 
patients who have had multiple homologous blood 
transfusions during both coronary artery and peri- 
pheral vascular surgery. Such patients present sig- 
nificant problems in cross-matching because of 
alloimmunisation, the formation of antibodies to 
human leukocyte antigens. Also, there are practical 
considerations regarding the availability and cost of 
large quantities of homologous blood. There is also a 
group of patients who, for religious reasons, refuse to 
accept homologous blood and whose surgery must be 
performed without blood. The present study aims to 
minimise homologous bleed requirements in patients 
undergoing elective abdominal aortic aneurysm repair 
using IAT, and to determine if this affected the in- 
cidence of SIRS/sepsis and the duration of post- 
operative hospital stay. 
The median blood requirements for the homologous 
group were 2.96 units/case and 3.26 units/case for 
the autologous group, similar to previous reports. 22-23 
Eighty-six percent of patients in the autologous group 
avoided homologous transfusions, and 3.8% of 
patients in the homologous group did not require a 
transfusion. Therefore, IAT saved a median of 2.6 units 
of homologous blood/case, which is an improvement 
on previous published reports. =24 This may represent 
improved haemoconcentration during the wash cycle 
in the currently available cell savers, or the change 
in current transfusion policies, which avoids using 
arbitrary postoperative 'transfusion triggers' such as 
10 g/dl .  
There are several studies demonstrating the effects 
of blood transfusion on the rate of infected com- 
plications.4'25-27; however, they were retrospective and 
lacked controls. Our pilot study was prospective and 
randomised, with those patients receiving autologous 
blood acting as the control population. The factors 
which are known to predispose to infection, such as 
the degree of difficulty of the surgical procedure, 
anaesthetic time and intraoperative blood loss were 
well balanced between the study groups. 
Our data demonstrate that patients undergoing 
elective AAA surgery who require 3-4 units of ho- 
mologous blood are much more likely to develop 
postoperative infections compared to those patients 
receiving autologous blood. In the patient receiving 
more than 4 Units of homologous blood, the infection 
risk was similar between the HBT and IAT groups. 
Several studies have indicated that haemorrhage con- 
tributes to the induction of an overall state of non- 
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responsiveness of the immune system, resulting in a 
reduced ability to combat infectious challenges. 28'29 
In addition there may be a synergistic effect of haem- 
orrhage and homologous blood transfusion on 
immunosuppression. In the homologous blood group 
patients went on to develop overt sepsis, while in the 
autologous group they developed SIRS only, with 
a faster resolution of their infectious complication 
(median stay of 12 days vs. 18 days). 
In summary, we found that it is possible to reduce 
significantly the exposure of patients undergoing elect- 
ive infrarenal AAA repair to homologous blood using 
IAT alone. The greater the amount of homologous 
blood transfused, the greater the risk of infection. We 
hypothesise that this is due in part to the immuno- 
suppressive effects of homologous blood trans- 
fusions, 27 and would recommend that patients under- 
going AAA surgery be offered the opportunity of 
autologous blood transfusion. 
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